tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market
NTLA
Intellia Therapeutics
RESEARCH TOOLSreports
Want to see NTLA full AI Analyst Report?

Intellia Therapeutics (NTLA) Income Statement

4,762 Followers

Intellia Therapeutics Income Statement

Last quarter (Q4 2025), Intellia Therapeutics's total revenue was $23.02M, an increase of 78.79% from the same quarter last year. In Q4, Intellia Therapeutics's net income was $-95.79M. See Intellia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 67.67M$ 57.88M$ 36.27M$ 52.12M$ 33.05M
Gross Profit
$ 51.75M$ 47.59M$ 27.30M$ 44.55M$ 26.16M
Operating Expenses
$ 492.74M$ 581.86M$ 542.59M$ 502.71M$ 294.01M
Depreciation and Amortization
$ 15.92M$ 10.29M$ 8.98M$ 7.57M$ 6.89M
EBITDA
$ -396.77M$ -523.98M$ -506.31M$ -450.59M$ -260.96M
Operating Income
$ -440.99M$ -534.26M$ -515.29M$ -458.16M$ -267.85M
Other Income/Expenses
$ 28.30M$ 15.24M$ 34.10M$ -16.02M$ -42.00K
Pretax Income
$ -412.69M$ -519.02M$ -481.19M$ -474.19M$ -267.89M
Net Income
$ -412.69M$ -519.02M$ -481.19M$ -474.19M$ -267.89M
Per Share Metrics
Basic EPS
$ -3.81$ -5.25$ -5.42$ -6.16$ -3.78
Diluted EPS
$ -3.81$ -5.25$ -5.42$ -6.16$ -3.78
Weighted Average Shares Outstanding
 108.38M 98.85M 88.77M 76.97M 70.89M
Weighted Average Shares Outstanding (Diluted)
 108.38M 98.85M 88.77M 76.97M 70.89M
Currency in USD

Intellia Therapeutics Earnings and Revenue History